FI108775B - Menetelmä enterotoksigeenisten E. coli -bakteereiden ihmisessä aiheuttamaa suolistoinfektiota vastaan vaikuttavan rokotekoostumuksen tuottamiseksi - Google Patents

Menetelmä enterotoksigeenisten E. coli -bakteereiden ihmisessä aiheuttamaa suolistoinfektiota vastaan vaikuttavan rokotekoostumuksen tuottamiseksi Download PDF

Info

Publication number
FI108775B
FI108775B FI933728A FI933728A FI108775B FI 108775 B FI108775 B FI 108775B FI 933728 A FI933728 A FI 933728A FI 933728 A FI933728 A FI 933728A FI 108775 B FI108775 B FI 108775B
Authority
FI
Finland
Prior art keywords
cfa
coli
bacteria
antigens
strains
Prior art date
Application number
FI933728A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI933728A (fi
FI933728A0 (fi
Inventor
Jan Holmgren
Ann-Mari Svennerholm
Original Assignee
Jan Holmgren
Svennerholm Ann Mari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Holmgren, Svennerholm Ann Mari filed Critical Jan Holmgren
Publication of FI933728A0 publication Critical patent/FI933728A0/fi
Publication of FI933728A publication Critical patent/FI933728A/fi
Application granted granted Critical
Publication of FI108775B publication Critical patent/FI108775B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/848—Escherichia
    • Y10S435/849—Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI933728A 1991-02-26 1993-08-25 Menetelmä enterotoksigeenisten E. coli -bakteereiden ihmisessä aiheuttamaa suolistoinfektiota vastaan vaikuttavan rokotekoostumuksen tuottamiseksi FI108775B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9100556A SE9100556D0 (sv) 1991-02-26 1991-02-26 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans
SE9100556 1991-02-26
PCT/SE1992/000110 WO1992014487A1 (en) 1991-02-26 1992-02-25 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans
SE9200110 1992-02-25

Publications (3)

Publication Number Publication Date
FI933728A0 FI933728A0 (fi) 1993-08-25
FI933728A FI933728A (fi) 1993-10-25
FI108775B true FI108775B (fi) 2002-03-28

Family

ID=20381987

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933728A FI108775B (fi) 1991-02-26 1993-08-25 Menetelmä enterotoksigeenisten E. coli -bakteereiden ihmisessä aiheuttamaa suolistoinfektiota vastaan vaikuttavan rokotekoostumuksen tuottamiseksi

Country Status (22)

Country Link
US (1) US6558678B1 (de)
EP (1) EP0573527B1 (de)
JP (1) JP3169608B2 (de)
KR (1) KR100221452B1 (de)
AT (1) ATE170755T1 (de)
AU (1) AU663864B2 (de)
BG (1) BG61683B1 (de)
BR (1) BR9205677A (de)
CA (1) CA2104877C (de)
CZ (1) CZ281556B6 (de)
DE (1) DE69226944T2 (de)
DK (1) DK0573527T3 (de)
ES (1) ES2123550T3 (de)
FI (1) FI108775B (de)
HU (1) HU213924B (de)
NO (1) NO307867B1 (de)
OA (1) OA09865A (de)
RO (1) RO109819B1 (de)
RU (1) RU2127121C1 (de)
SE (1) SE9100556D0 (de)
SK (1) SK280919B6 (de)
WO (1) WO1992014487A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118758B1 (en) * 1997-01-24 2006-10-10 The United States Of America As Represented By The Secretary Of The Army Transformed bacteria producing CS6 antigens as vaccines
SE9401921D0 (sv) * 1994-06-03 1994-06-03 Sbl Vaccin Ab A method of cultivating bacteria
US7094883B1 (en) 1996-08-02 2006-08-22 The United States Of America As Represented By The Secretary Of The Army Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein
US7404961B2 (en) 1996-08-02 2008-07-29 The United States Of America As Represented By The Secretary Of The Army Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins
US5994078A (en) * 1997-07-31 1999-11-30 Maine Medical Center Stable encapsulated reference nucleic acid and method of making
SE515285C2 (sv) * 1998-12-18 2001-07-09 Sbl Vaccin Ab Oralt vaccin mot diarré
GB0121998D0 (en) * 2001-09-11 2001-10-31 Acambis Res Ltd Attenuated bacteria useful in vaccines
JP5100122B2 (ja) * 2003-10-31 2012-12-19 ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア 細菌の病原因子とそれらの使用
EP1981536A4 (de) * 2006-02-01 2012-03-14 Gotovax Ab Kolonisationsfaktorantigene enterotoxigener escherichia coli in rekombinanten bakterien
BR112013027845A2 (pt) * 2011-05-18 2017-01-03 Ajinomoto Kk Imunoestimulante, ração, método para produzir um imunoestimulante, e, método para imunoestimulação
US8926980B2 (en) 2011-07-11 2015-01-06 Camas Incorporated Compositions against bacterial toxins
DK2750701T3 (en) * 2011-09-12 2016-01-11 Scandinavian Biopharma Holding Ab PROCEDURE FOR INCREASING ETEC-CS6 ANTIGEN PRESENTATION ON CELL SURFACE AND THEREFORE AVAILABLE PRODUCTS
BR112014005601B1 (pt) 2011-09-12 2020-09-29 Scandinavian Biopharma Holding Ab Vacina oral para a imunização contra a diarréia induzida pela etec
RO132299A3 (ro) 2017-06-06 2018-12-28 Fântână Raul Sorin Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD62894A (de) *
DE1208038B (de) * 1963-08-01 1965-12-30 Wellcome Found Verfahren zur Herstellung von Impfstoffen gegen Coli-Infektionen
GB1472624A (en) * 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
US4338298A (en) * 1980-04-04 1982-07-06 Endowment And Research Foundation At Montana State University Vaccine for passive immunization against enteric colibacillosis and method of use
DK41885A (da) * 1985-01-31 1986-11-13 Slagteriernes Forskningsinst 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen
DE3650065T2 (de) * 1985-07-31 1995-03-02 Univ Leland Stanford Junior Invasive Mikroorganismen.
FI76484C (fi) 1986-02-03 1988-11-10 Osmo Norvasto Kundstol.
JPS6399020A (ja) * 1986-06-05 1988-04-30 ベイラ−　カレツジ　オブ　メデイシン ワクチンとその製法
SU1723116A1 (ru) * 1988-04-15 1992-03-30 Оренбургский Государственный Медицинский Институт Штамм бактерий BacILLUS SUвтILIS, используемый дл получени препарата дл профилактики и лечени воспалительных процессов и аллергических заболеваний
DE68929405T2 (de) * 1988-09-06 2003-02-06 Washington University, St. Louis Orale-immunisierung durch verwendung von transgenen pflanzen
SE9401921D0 (sv) * 1994-06-03 1994-06-03 Sbl Vaccin Ab A method of cultivating bacteria

Also Published As

Publication number Publication date
BG61683B1 (bg) 1998-03-31
DE69226944D1 (de) 1998-10-15
HU213924B (en) 1997-11-28
AU1330892A (en) 1992-09-15
CA2104877C (en) 2005-10-04
BG98070A (bg) 1994-06-30
CZ174293A3 (en) 1994-04-13
SE9100556D0 (sv) 1991-02-26
CZ281556B6 (cs) 1996-11-13
DE69226944T2 (de) 1999-02-11
ES2123550T3 (es) 1999-01-16
HUT67198A (en) 1995-02-28
RU2127121C1 (ru) 1999-03-10
JPH06505730A (ja) 1994-06-30
NO933037D0 (no) 1993-08-25
OA09865A (en) 1994-08-15
WO1992014487A1 (en) 1992-09-03
US6558678B1 (en) 2003-05-06
SK280919B6 (sk) 2000-09-12
ATE170755T1 (de) 1998-09-15
BR9205677A (pt) 1994-05-17
FI933728A (fi) 1993-10-25
RO109819B1 (ro) 1995-06-30
CA2104877A1 (en) 1992-08-27
EP0573527A1 (de) 1993-12-15
NO307867B1 (no) 2000-06-13
EP0573527B1 (de) 1998-09-09
NO933037L (no) 1993-08-25
HU9302410D0 (en) 1993-11-29
KR100221452B1 (ko) 1999-09-15
DK0573527T3 (da) 1999-06-07
SK91093A3 (en) 1994-05-11
KR930703015A (ko) 1993-11-29
AU663864B2 (en) 1995-10-26
FI933728A0 (fi) 1993-08-25
JP3169608B2 (ja) 2001-05-28

Similar Documents

Publication Publication Date Title
Tacket et al. Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers
FI108775B (fi) Menetelmä enterotoksigeenisten E. coli -bakteereiden ihmisessä aiheuttamaa suolistoinfektiota vastaan vaikuttavan rokotekoostumuksen tuottamiseksi
Gadde et al. Passive immunization with hyperimmune egg-yolk IgY as prophylaxis and therapy for poultry diseases–a review
Levine et al. Fimbrial vaccines
Åhrén et al. Intestinal antibody response after oral immunization with a prototype cholera B subunit—colonization factor antigen enterotoxigenic Escherichia coli vaccine
Levine et al. A roadmap for enterotoxigenic Escherichia coli vaccine development based on volunteer challenge studies
JP2010531653A (ja) 腸管毒素原性大腸菌の定着因子（ｃｆ）抗原を発現するためのハイブリッドオペロン
Sizemore et al. Enterotoxigenic Escherichia coli virulence factors and vaccine approaches
Iankov et al. Protective efficacy of IgA monoclonal antibodies to O and H antigens in a mouse model of intranasal challenge with Salmonella enterica serotype Enteritidis
US5593679A (en) Poultry vaccine against E. coli air sac inflammation and septicaemia
Lasaro et al. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli
Mukerjee Preliminary studies on the development of a live oral vaccine for anti-cholera immunization
Burr et al. Prevention of disease in ferrets fed an inactivated whole cell Campylobacter jejuni vaccine
Shin et al. Effective methods for the production of immunoglobulin Y using immunogens of Bordetella bronchiseptica, Pasteurella multocida and Actinobacillus pleuropneumoniae
HUT77574A (hu) Eljárás fokozott antigénaktivitású Helicobacter sp. és azt tartalmazó vakcina előállítására
Boesman-Finkelstein et al. Protection in rabbits induced by the Texas Star-SR attenuated A-B+ mutant candidate live oral cholera vaccine
Jingushi et al. Antigenic analysis of Serratia marcescens fimbriae with monoclonal antibodies
Svennerholm et al. Immunity to enterotoxin-producing bacteria
Holmgren et al. Vaccines against diarrheal diseases
JP2023113631A (ja) クロストリジウム類毒素を含むワクチン
IE54590B1 (en) Detoxified e. coli neurotoxin, preparation thereof and immunological preparations containing it
WO2020008475A1 (en) Novel shigella vaccine formulation and process to prepare thereof
Carrasco Medina Investigation of a leukotoxin containing immune stimulating complex (ISCOM) vaccine and early immunization in dairy calves
Svennerholm et al. Mucosal immune responses against enterotoxigenic Escherichia coli [ETEC] in humans
Whang et al. Effect of Heat on Antigenicity and Immunogenicity of the Antigenic Determinant Shared by Haemophilus influenzae Type b and Escherichia coli K100